BioSpace News Archive

Ra Pharmaceuticals, Inc. today announced that senior management will present at the following upcoming investor conferences

Q1'19 revenue of $551.8 million increased 1% as-reported, or 3% in constant currency, from the prior-year period.

In acknowledgement of World Antibiotic Awareness Week, Nov. 12-18, a new survey examining Canadians’ understanding of antimicrobial resistance (AMR) reveals that many are unfamiliar with and unconcerned about the threat of drug resistance.1,2

MEI Pharma, Inc. today announced that Daniel P. Gold, Ph.D. will present a corporate update at the Stifel 2018 Healthcare Conference.

Tocagen Inc. today announced three presentations of updated clinical and preclinical data at the Society for Immunotherapy of Cancer.

Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the forefront of cell-delivered oncolytic viruses for the treatment of cancer, today announced that data from its clinical studies in late-stage cancer patients will be presented at the Society for Immunotherapy of Cancer (SITC) upcoming 33rd Annual Meeting,

Codiak BioSciences, Inc., the leading exosome therapeutics company, today announced results from preclinical studies demonstrating the potential of Codiak’s proprietary engineered exosome therapeutic, exoSTING.

Nektar Therapeutics announced today that it will webcast an analyst and investor conference call with melanoma specialists and company management on Saturday, November 10, 2018 at 9:00 a.m. EST in Washington, D.C. during the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting.

Biocept, Inc. announces that it will release financial results for the three and nine months ended September 30, 2018, after the market closes on Tuesday, November 13, 2018.

Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced that preclinical data on CTX-471,